31.01.2022
To the attention of interested persons
An EU4Health Joint Action for the rapid assessment of multinational COVID-19 trials will start in February 2022.
To provide potential clinical trial developers and sponsors with information about this joint action, the coordinators and the steering committee have organised an informative session for stakeholders, which will take place on 3 February, from 10:00 to 12:00.
The scope is limited to COVID-19 therapeutic trials submitted under the Clinical Trials Regulation (Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC)
Registration for this event can be done by accessing the following link:
EU4H-2021-JA-01
Link: https://scic.ec.europa.eu/ew/register/dgscic/JA_02_22/e/lk/g/36170/k/
The deadline for registration is 31 January 2022.
Attached: the Agenda of the event of 3 February and the login instructions.
descarca programul …
descarca instrucțiunile pentru logare …